Dimethylamine

Dimethylamine

SCHEMBL2524428

Brc1ccc2nc(-c3ccccc3)sc2c1.CNC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 16/20 0.72
MAPT P10636 3/20 0.59
KDM4E B2RXH2 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MEN1 O00255 2/20 0.59
GLA P06280 2/20 0.59
GAA P10253 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 1/20 0.59
PKM P14618 1/20 0.59
HPGD P15428 1/20 0.59
LMNA P02545 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
SNCA P37840 1/20 0.50
SULT1A1 P50225 1/20 0.49
MAOB P27338 1/20 0.49
ILK Q13418 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30903625 0.94 APP (0.71) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL15414023 0.94 APP (0.71) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL31120302 0.84 APP (0.81) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL2466803 0.84 APP (1.00) APPMAPTKDM4ESMN1; SMN2MEN1
Dimethylamine SCHEMBL27718704 0.82 APP (0.72) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL595453 0.81 KDM4E (0.57) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL2461395 0.78 APP (1.00) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL4806067 0.78 APP (0.72) APPMAPTKDM4ESMN1; SMN2GLA
SCHEMBL14075967 0.78 APP (0.72) APPMAPTKDM4ESMN1; SMN2MEN1
SCHEMBL4157441 0.78 APP (0.72) APPMAPTKDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365974-B1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2013-12-25 EP disclosed
US-20110250136-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME SNU R&DB FOUNDATION (KR) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110250136-A1 FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME APBA1, APP, PSEN1 APP 2/4885MAPT 5/4885KDM4E 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.